AXSM (AXSM) Stock Price & Analysis
AXSM (AXSM) rose 0.00% to USD 241 as of July 25, 2026 at 03:50 UTC, according to Nexqual real-time market data.
AXSM last closed at USD 241; the session ranged USD 237.78–242.89 on volume of 411,997 shares. Market capitalization is —, with a 52-week range of USD 96.09–260.19 (NGM). Source: Nexqual, July 25, 2026 at 03:50 UTC.
Key Statistics (as of July 25, 2026 at 03:50 UTC)
| Price | USD 241 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 241 |
| Open | USD 241 |
| Day Range | USD 237.78 – 242.89 |
| 52-Week Range | USD 96.09 – 260.19 |
| Volume | 411,997 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (AXSM)
Nexqual's technical model rates AXSM "BUY" based on 4 bullish and 1 bearish signals across 125 daily candles, as of July 25, 2026 at 03:50 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 53.54 (neutral) |
| vs SMA50 | Above (USD 238.53) |
| MACD | -0.26 (negative) |
Earnings (AXSM)
| Next Earnings Date | 2026-08-10 |
|---|---|
| EPS Estimate | USD -0.84 |
| Revenue Estimate | $221.60M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD -1.26 vs est -0.86 ▼ miss |
| 2025-12-31 | USD -0.56 vs est -0.73 ▲ beat |
| 2025-09-30 | USD -0.94 vs est -0.9 ▼ miss |
| 2025-06-30 | USD -0.97 vs est -1.09 ▲ beat |
Source: Nexqual, July 25, 2026 at 03:50 UTC.
Financials & Fundamentals (AXSM)
| Total Revenue | $708.24M |
|---|---|
| Revenue Growth (YoY) | +57.40% |
| Gross Margin | +92.60% |
| Operating Margin | -32.83% |
| Profit Margin | -26.59% |
| ROE | -349.38% |
| Debt / Equity | 402.84 |
| Current Ratio | 1.39 |
| Total Cash | $305.11M |
| Total Debt | $219.90M |
| Free Cash Flow | $-3.85M |
Source: Nexqual, July 25, 2026 at 03:50 UTC.
Ownership (AXSM)
| Insider Ownership | +15.35% |
|---|---|
| Institutional Ownership | +75.67% |
| Shares Outstanding | 51.46M |
| Float | 43.56M |
| Short % of Float | +8.02% |
Source: Nexqual, July 25, 2026 at 03:50 UTC.
From AXSM's Latest SEC 10-K Filing (filed 2026-02-23)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| TGTX | TG Therapeutics, Inc. | USD 56.04 | ▲ 6.38% |
| MDGL | Madrigal Pharmaceuticals, Inc. | USD 544.51 | ▲ 1.28% |
| AUPH | Aurinia Pharmaceuticals Inc | USD 15.35 | ▲ 0.13% |
| BBIO | BridgeBio Pharma, Inc. | USD 84.02 | ▲ 1.65% |
| IOVA | Iovance Biotherapeutics, Inc. | USD 4.99 | ▼ 3.48% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:50 UTC. This page is informational and not investment advice.